Epizyme, Inc.
EPZMDelisted Aug 12, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001571498
Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.
Holders of 5% or more of EPZM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Epizyme, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Epizyme, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
21 Schedule 13D and 13G filings on Epizyme, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Sep 8, 2022 | Primecap Management Co | 13G/AOld format | – | – | – | SEC |
| Aug 15, 2022 | Ipsen, S.A. | 13D/AOld format | – | – | – | SEC |
| Aug 9, 2022 | Primecap Management Co | 13G/AOld format | – | – | – | SEC |
| Jul 7, 2022 | Ipsen, S.A. | 13DOld format | – | New | – | SEC |
| Jun 28, 2022 | RPI Finance Trust | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Primecap Management Co | 13G/AOld format | – | – | – | SEC |
| Feb 9, 20225:22 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2022 | Primecap Management Co | 13G/AOld format | – | – | – | SEC |
| Feb 7, 20226:12 AM ET | HUTCHMED (China) Ltd | 13D/AOld format | – | – | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 1, 2022 | RPI Finance Trust | 13D/AOld format | – | – | – | SEC |
| Aug 16, 20217:20 AM ET | HUTCHMED (China) Ltd | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Primecap Management Co | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20219:56 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Epizyme, Inc. shares.
No Form 144 notices for Epizyme, Inc. are on file.